Table 1 Clinical background
From: Developing a diagnostic method for latent tuberculosis infection using circulating miRNA
Basic patient information | Diagnosis of TB | ||||||
|---|---|---|---|---|---|---|---|
Sample ID | Diagnosis | Age | Sex | Complications | PCR | QFT | Sputum culture |
LP01 | LTBI | 44 | F | (−) | 6.52 | (−) | |
LP02 | LTBI | 52 | M | (−) | 5.6 | (−) | |
LP03 | LTBI | 54 | F | (−) | 2.03 | (−) | |
LP04 | LTBI | 52 | F | (−) | 1.13 | (−) | |
LP05 | LTBI | 51 | F | (−) | 0.87 | (−) | |
LP06 | LTBI | 61 | F | (−) | 7.8 | (−) | |
LP07 | LTBI | 57 | F | (−) | > 10 | (−) | |
LP08 | LTBI | 24 | F | (−) | 7.59 | (−) | |
LP09 | LTBI | 48 | M | (−) | > 10 | (−) | |
LP10 | LTBI | 50 | F | (−) | 2.45 | (−) | |
LP16 | LTBI | 78 | M | NP | 0.34 | (−) | |
LP17 | LTBI | 57 | M | NP | 2.38 | (−) | |
LP18 | LTBI | 67 | F | NP | 0.98 | (−) | |
LP22 | LTBI | 70 | M | Gastric cancer | NP | 2.45 | (−) |
LP25 | LTBI | 75 | M | IP | NP | 9.5 | (−) |
LP27 | LTBI | 81 | F | NP | 1.84 | (−) | |
TP01 | TB | 49 | F | (−) | −0.05 | (−) | |
TP02 | TB | 56 | M | Colon cancer | NP | 2.23 | (+) |
TP03 | TB | 62 | F | Pleuritis | (−) | 3.27 | (−) |
TP04 | TB | 86 | M | (+) | NP | (+) | |
TP05 | TB | 83 | M | (+) | T-SPOT (+) | (+) | |
TP06 | TB | 75 | M | (−) | NP | (−) | |
TP07 | TB | 62 | M | CLL | (+) | T-SPOT (+) | (+) |
TP08 | TB | 62 | M | Tongue cancer | (+) | NP | (+) |
TP09 | TB | 85 | F | NP | NP | (+) | |
TP10 | TB | 76 | M | Miliary TB | (−) | NP | (+) |
TP12 | TB | 35 | F | (+) | NP | (+) | |
TP13 | TB | 29 | M | Lymph node TB | LN (+) | NP | (−) |
TP17 | TB | 29 | F | (+) | NP | (+) | |
TP25 | TB | 54 | F | OC | (+) | NP | (+) |
TP33 | TB | 46 | F | (+) | NP | (+) | |
TP41 | TB | 51 | M | DM | (+) | NP | (+) |